PCR's Got Talent - Round 1 - Session 2

Session comprising selected EuroPCR 2022 Abstract submissions

Facilitators: E. Grube, J. Kefer
SHOW MORE

Summary

Consult this session to discover a selection of cases presented during the round 1 of PCR's Got Talent at EuroPCR 2022: tricuspid regurgitation and right ventricular-pulmonary artery coupling, TAVI vs. medical therapy in patients with borderline severe classical LFLG AS, the LIRA sizing method of TAVR prostheses in raphe-type bicuspid aortic valves, and more!

Presentations available when logged in:

  • Tricuspid regurgitation and right ventricular-pulmonary artery coupling
  • QFR-based assessment of functional accuracy of everyday interventional practice
  • Mechanisms of residual shunt after PFO closure with the NobleStitch system
  • TAVR in patients with small annuli: different outcome with SEV and BEV?
  • Baseline measures of physical activity predict clinical outcomes in TAVI patient
  • TAVI vs. medical therapy in patients with borderline severe classical LFLG AS
  • HALT: an independent predictor of structural valve deterioration following TAVI
  • Implantation of contemporary transcatheter aortic valves in small aortic annuli
  • Impact of frailty in patients undergoing TAVI: insights from the Observant2 study
  • TAVI in everyday practice: can we neglect mild paravalvular leak?
  • Myval vs. alternative balloon- and self-expandable TAVI ECG comparison
  • The LIRA sizing method of TAVR prostheses in raphe-type bicuspid aortic valves
  • Commissural vs. coronary optimised alignment during TAVI
  • Right atrial pacing discriminating permanent pacemaker necessity in TAVI
  • Coronary access after valve-in-valve TAVI with ACURATE neo: ex vivo analysis
  • The effect of coronary lesion complexity and PCI on long-term post-TAVR outcomes
  • Impact of CAD on TAVI: real-world data from the OBSERVANT 2 registry
  • Quantitative flow ratio based on Murray fractal law: comparative diagnostic accuracy of single versus two angiographic views
  • Full vs. partial heparin reversal for the prevention of bleedings after TAVR
  • Next-generation balloon-expandable Myval device in low-risk aortic stenosis